Chemical biology study shows oleuropein reduces diabetes organ damage in Psammomys obesus, indicating its potential for management of metabolic syndrome.
Key Points
Oleuropein administration significantly reduced kidney weight and preserved renal health in diabetic conditions.
Biochemical normalization of erythrocyte biomarkers was achieved, evidenced by decreased aldose reductase and sorbitol dehydrogenase activities.
Antioxidant effects were showcased through restored levels of malondialdehyde, superoxide dismutase, and catalase in retinal tissues.
Oleuropein's protective effects point to its role in vascular integrity and diabetes management, suggesting clinical relevance.